NCT06993844 2026-03-17Phase 1/2 Study of ETX-636 in Participants With Advanced Solid TumorsEnsem TherapeuticsPhase 1/2 Recruiting233 enrolled
NCT04997902 2025-12-23Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)Kura Oncology, Inc.Phase 1/2 Completed45 enrolled
NCT05683418 2025-07-22A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With HR+ Breast Cancer and Other Select Solid TumorsTotus MedicinesPhase 1 Recruiting241 enrolled
NCT04774952 2025-04-15Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid TumorsRevolution Medicines, Inc.Phase 1 Completed58 enrolled
NCT02644122 2018-07-11SF1126 in Recurrent or Progressive SCCHN and Mutations in PIK3CA Gene and/or PI-3 Kinase Pathway GenesUniversity of California, San DiegoPhase 2 Terminated1 enrolled 6 charts
NCT01204099 2018-05-16Study of PX-866 and Docetaxel in Solid TumorsSeagen Inc.Phase 1/2 Completed223 enrolled